<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39407724</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Severe Bacterial Superinfection of Influenza Pneumonia in Immunocompetent Young Patients: Case Reports.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5665</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13195665</ELocationID><Abstract><AbstractText>Influenza can lead to or coexist with severe bacterial pneumonia, with the potential to permanently damage lung tissue, refractory to conservative treatment in the post-COVID-19 period. It can lead to serious complications; therefore, annual vaccinations are recommended. This case series with a literature review pertains to two young female patients with an insignificant past medical history, who required emergency lobectomy due to bacterial complications after influenza infection. Urgent lobectomy proves to be a feasible therapeutic option for selected patients with pleural complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Białka</LastName><ForeName>Szymon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5923-2469</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-803 Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zieliński</LastName><ForeName>Michał</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Lung Diseases and Tuberculosis, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-803 Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latos</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6429-7638</Identifier><AffiliationInfo><Affiliation>Department of Lung Diseases and Tuberculosis, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-803 Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skurzyńska</LastName><ForeName>Marlena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Department of Anaesthesiology and Intensive Care, Independent Public Clinical Hospital No. 1., 41-800 Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Żak</LastName><ForeName>Michał</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Student Scientific Society at the Department of Anaesthesiology and Intensive Care, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palaczyński</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-803 Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skoczyński</LastName><ForeName>Szymon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1796-7659</Identifier><AffiliationInfo><Affiliation>Department of Lung Diseases and Tuberculosis, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-803 Zabrze, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PCN-1-25/N/2/K as well as PCN-1-090/N/2/K</GrantID><Agency>Medical University of Silesia</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bacterial coinfection</Keyword><Keyword MajorTopicYN="N">infectious diseases</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">lobectomy</Keyword><Keyword MajorTopicYN="N">respiratory infections</Keyword><Keyword MajorTopicYN="N">unvaccinated</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword><Keyword MajorTopicYN="N">young patients</Keyword></KeywordList><CoiStatement>All authors declare that they have no conflicts of interest regarding this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39407724</ArticleId><ArticleId IdType="pmc">PMC11476596</ArticleId><ArticleId IdType="doi">10.3390/jcm13195665</ArticleId><ArticleId IdType="pii">jcm13195665</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jung H.S., Kang B.J., Ra S.W., Seo K.W., Jegal Y., Jun J.B., Jung J., Jeong J., Jeon H.J., Ahn J.S., et al. Elucidation of Bacterial Pneumonia-Causing Pathogens in Patients with Respiratory Viral Infection. Tuberc. Respir. Dis. 2017;80:358–367. doi: 10.4046/trd.2017.0044.</Citation><ArticleIdList><ArticleId IdType="doi">10.4046/trd.2017.0044</ArticleId><ArticleId IdType="pmc">PMC5617852</ArticleId><ArticleId IdType="pubmed">28905531</ArticleId></ArticleIdList></Reference><Reference><Citation>Schüz M.L., Dallmeyer L., Fragkou P.C., Omony J., Krumbein H., Hünerbein B.L., Skevaki C. Global Prevalence of Respiratory Virus Infections in Adults and Adolescents during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Int. J. Infect. Dis. 2023;137:16–24. doi: 10.1016/j.ijid.2023.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.10.001</ArticleId><ArticleId IdType="pubmed">37806653</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19.  [(accessed on 18 May 2024)].  Available online:  https://www.ecdc.europa.eu/en/covid-19.</Citation></Reference><Reference><Citation>Aho Glele L.S., de Rougemont A. Non-Pharmacological Strategies and Interventions for Effective COVID-19 Control: A Narrative Review. J. Clin. Med. 2023;12:6465. doi: 10.3390/jcm12206465.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12206465</ArticleId><ArticleId IdType="pmc">PMC10607620</ArticleId><ArticleId IdType="pubmed">37892603</ArticleId></ArticleIdList></Reference><Reference><Citation>Miron V.D., Bar G., Filimon C., Craiu M. From COVID-19 to Influenza—Real-Life Clinical Practice in a Pediatric Hospital. Diagnostics. 2022;12:1208. doi: 10.3390/diagnostics12051208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12051208</ArticleId><ArticleId IdType="pmc">PMC9140149</ArticleId><ArticleId IdType="pubmed">35626363</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Regional Office for Europe and Stockholm: European Centre for Disease Prevention and Control  . Influenza Virus Characterization: Summary Report, Europe, March 2024. WHO Regional Office for Europe and Stockholm; Copenhagen, Denmark: 2024.  [(accessed on 2 July 2024)].  Available online:  http://apps.who.int/bookorders.</Citation></Reference><Reference><Citation>Daoud A., Laktineh A., Macrander C., Mushtaq A., Soubani A.O. Pulmonary Complications of Influenza Infection: A Targeted Narrative Review. Postgrad. Med. 2019;131:299–308. doi: 10.1080/00325481.2019.1592400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00325481.2019.1592400</ArticleId><ArticleId IdType="pubmed">30845866</ArticleId></ArticleIdList></Reference><Reference><Citation>Iuliano A.D., Roguski K.M., Chang H.H., Muscatello D.J., Palekar R., Tempia S., Cohen C., Gran J.M., Schanzer D., Cowling B.J., et al. Estimates of Global Seasonal Influenza-Associated Respiratory Mortality: A Modelling Study. Lancet. 2018;391:1285–1300. doi: 10.1016/S0140-6736(17)33293-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)33293-2</ArticleId><ArticleId IdType="pmc">PMC5935243</ArticleId><ArticleId IdType="pubmed">29248255</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluijs K., Poll T., Lutter R., Juffermans N.P., Schultz M.J. Bench-to-Bedside Review: Bacterial Pneumonia with Influenza—Pathogenesis and Clinical Implications. Crit. Care. 2010;14:219. doi: 10.1186/cc8893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8893</ArticleId><ArticleId IdType="pmc">PMC2887122</ArticleId><ArticleId IdType="pubmed">20459593</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholtissek C. Molecular Evolution of Influenza Viruses. Virus Genes. 1995;11:209–215. doi: 10.1007/BF01728660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01728660</ArticleId><ArticleId IdType="pubmed">8828147</ArticleId></ArticleIdList></Reference><Reference><Citation>Paget J., Caini S., Del Riccio M., van Waarden W., Meijer A. Has Influenza B/Yamagata Become Extinct and What Implications Might This Have for Quadrivalent Influenza Vaccines? Eurosurveillance. 2022;27:2200753. doi: 10.2807/1560-7917.ES.2022.27.39.2200753.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.39.2200753</ArticleId><ArticleId IdType="pmc">PMC9524051</ArticleId><ArticleId IdType="pubmed">36177871</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens D.M., Taubenberger J.K., Fauci A.S. Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness. J. Infect. Dis. 2008;198:962–970. doi: 10.1086/591708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591708</ArticleId><ArticleId IdType="pmc">PMC2599911</ArticleId><ArticleId IdType="pubmed">18710327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamas M.A., Fraser D., Neyses L. Cardiovascular Manifestations Associated with Influenza Virus Infection. Int. J. Cardiol. 2008;130:304–309. doi: 10.1016/j.ijcard.2008.04.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2008.04.044</ArticleId><ArticleId IdType="pubmed">18625525</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomassini L., Ferretti F., Uvelli A., Fedeli D., Gualtieri G. Fatal Viral and Bacterial Septicemia in a Seventeen-Year-Old Woman with Immunodepressive Influenza A H1N1: An Autopsy Case. Clin. Ter. 2024;175:95–100. doi: 10.7417/CT.2024.5039.</Citation><ArticleIdList><ArticleId IdType="doi">10.7417/CT.2024.5039</ArticleId><ArticleId IdType="pubmed">38571465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanada S., Pirzadeh M., Carver K.Y., Deng J.C. Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia. Front. Immunol. 2018;9:2640. doi: 10.3389/fimmu.2018.02640.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02640</ArticleId><ArticleId IdType="pmc">PMC6250824</ArticleId><ArticleId IdType="pubmed">30505304</ArticleId></ArticleIdList></Reference><Reference><Citation>Cillóniz C., Ewig S., Menéndez R., Ferrer M., Polverino E., Reyes S., Gabarrús A., Marcos M.A., Cordoba J., Mensa J., et al. Bacterial Co-Infection with H1N1 Infection in Patients Admitted with Community Acquired Pneumonia. J. Infect. 2012;65:223–230. doi: 10.1016/j.jinf.2012.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2012.04.009</ArticleId><ArticleId IdType="pmc">PMC7132402</ArticleId><ArticleId IdType="pubmed">22543245</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscedere J., Ofner M., Kumar A., Long J., Lamontagne F., Cook D., McGeer A., Chant C., Marshall J., Jouvet P., et al. The Occurrence and Impact of Bacterial Organisms Complicating Critical Care Illness Associated with 2009 Influenza A(H1N1) Infection. Chest. 2013;144:39–47. doi: 10.1378/chest.12-1861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.12-1861</ArticleId><ArticleId IdType="pubmed">23392627</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris A., Beck J.M., Schloss P.D., Campbell T.B., Crothers K., Curtis J.L., Flores S.C., Fontenot A.P., Ghedin E., Huang L., et al. Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers. Am. J. Respir. Crit. Care Med. 2013;187:1067–1075. doi: 10.1164/rccm.201210-1913OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201210-1913OC</ArticleId><ArticleId IdType="pmc">PMC3734620</ArticleId><ArticleId IdType="pubmed">23491408</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolter N., Tempia S., Cohen C., Madhi S.A., Venter M., Moyes J., Walaza S., Malope-Kgokong B., Groome M., du Plessis M., et al. High Nasopharyngeal Pneumococcal Density, Increased by Viral Coinfection, Is Associated with Invasive Pneumococcal Pneumonia. J. Infect. Dis. 2014;210:1649–1657. doi: 10.1093/infdis/jiu326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu326</ArticleId><ArticleId IdType="pubmed">24907383</ArticleId></ArticleIdList></Reference><Reference><Citation>Edouard S., Million M., Bachar D., Dubourg G., Michelle C., Ninove L., Charrel R., Raoult D. The Nasopharyngeal Microbiota in Patients with Viral Respiratory Tract Infections Is Enriched in Bacterial Pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 2018;37:1725–1733. doi: 10.1007/s10096-018-3305-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-018-3305-8</ArticleId><ArticleId IdType="pubmed">30033505</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung R.K.-K., Zhou J.-W., Guan W., Li S.-K., Yang Z.-F., Tsui S.K.-W. Modulation of Potential Respiratory Pathogens by PH1N1 Viral Infection. Clin. Microbiol. Infect. 2013;19:930–935. doi: 10.1111/1469-0691.12054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12054</ArticleId><ArticleId IdType="pubmed">23167452</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger A.L., Chen E.C., Sittler T., Scheinerman A., Roubinian N., Yu G., Kim E., Pillai D.R., Guyard C., Mazzulli T., et al. A Metagenomic Analysis of Pandemic Influenza A (2009 H1N1) Infection in Patients from North America. PLoS ONE. 2010;5:e13381. doi: 10.1371/journal.pone.0013381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013381</ArticleId><ArticleId IdType="pmc">PMC2956640</ArticleId><ArticleId IdType="pubmed">20976137</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Bortolasci C.C., Puri B.K., Marx W., O’Neil A., Athan E., Walder K., Berk M., Olive L., Carvalho A.F., et al. The Cytokine Storms of COVID-19, H1N1 Influenza, CRS and MAS Compared. Can One Sized Treatment Fit All? Cytokine. 2021;144:155593. doi: 10.1016/j.cyto.2021.155593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155593</ArticleId><ArticleId IdType="pmc">PMC8149193</ArticleId><ArticleId IdType="pubmed">34074585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Tu W., Lam K.-T., Chow K.-H., Ho P.-L., Guan Y., Peiris J.S.M., Lau Y.-L. Lethal Coinfection of Influenza Virus and Streptococcus Pneumoniae Lowers Antibody Response to Influenza Virus in Lung and Reduces Numbers of Germinal Center B Cells, T Follicular Helper Cells, and Plasma Cells in Mediastinal Lymph Node. J. Virol. 2015;89:2013–2023. doi: 10.1128/JVI.02455-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02455-14</ArticleId><ArticleId IdType="pmc">PMC4338877</ArticleId><ArticleId IdType="pubmed">25428873</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdier V., Lilienthal F., Desvergez A., Gazaille V., Winer A., Paganin F. Severe Forms of Influenza Infections Admitted in Intensive Care Units: Analysis of Mortality Factors. Influenza Other Respir. Viruses. 2023;17:e13168. doi: 10.1111/irv.13168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13168</ArticleId><ArticleId IdType="pmc">PMC10359970</ArticleId><ArticleId IdType="pubmed">37483265</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuquemelle E., Soulis F., Villers D., Roche-Campo F., Ara Somohano C., Fartoukh M., Kouatchet A., Mourvillier B., Dellamonica J., Picard W., et al. Can Procalcitonin Help Identify Associated Bacterial Infection in Patients with Severe Influenza Pneumonia? A Multicentre Study. Intensive Care Med. 2011;37:796–800. doi: 10.1007/s00134-011-2189-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2189-1</ArticleId><ArticleId IdType="pmc">PMC7080069</ArticleId><ArticleId IdType="pubmed">21369807</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.Y., Cheong H.J., Heo J.Y., Noh J.Y., Yong H.S., Kim Y.K., Kang E.Y., Choi W.S., Jo Y.M., Kim W.J. Clinical, Laboratory and Radiologic Characteristics of 2009 Pandemic Influenza A/H1N1 Pneumonia: Primary Influenza Pneumonia versus Concomitant/Secondary Bacterial Pneumonia. Influenza Other Respir. Viruses. 2011;5:e535–e543. doi: 10.1111/j.1750-2659.2011.00269.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-2659.2011.00269.x</ArticleId><ArticleId IdType="pmc">PMC5780671</ArticleId><ArticleId IdType="pubmed">21682848</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerdes-Fenge H.F., Klein S., Schuldt H.M., Löbermann M., Köller K., Däbritz J., Reisinger E.C. Complications of Influenza in 272 Adult and Pediatric Patients in a German University Hospital during the Seasonal Epidemic 2017–2018. Wien. Med. Wochenschr. 2021;172:280–286. doi: 10.1007/s10354-021-00884-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10354-021-00884-0</ArticleId><ArticleId IdType="pmc">PMC8476975</ArticleId><ArticleId IdType="pubmed">34581968</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.D., Yu J.A., Bishop A., Weyant M.J., Pomerantz M. Thoracoscopic Lobectomy and Segmentectomy for Infectious Lung Disease. Ann. Thorac. Surg. 2012;93:1033–1040. doi: 10.1016/j.athoracsur.2012.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.01.012</ArticleId><ArticleId IdType="pubmed">22386091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Reimel B., Krishnadasen B., Cuschieri J., Klein M.B., Gross J., Karmy-Jones R., Reimel B., Krishnadasen B., Cuschieri J., Klein M., et al. Surgical Management of Acute Necrotizing Lung Infections. Can. Respir. J. 2006;13:369–373. doi: 10.1155/2006/760390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2006/760390</ArticleId><ArticleId IdType="pmc">PMC2683290</ArticleId><ArticleId IdType="pubmed">17036090</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeters K., Mesotten D., Willaert X., Deraedt K., Nauwelaers S., Lauwers G. Salvage Lobectomy to Treat Necrotizing SARS-CoV-2 Pneumonia Complicated by a Bronchopleural Fistula. Ann. Thorac. Surg. 2021;111:e241–e243. doi: 10.1016/j.athoracsur.2020.10.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2020.10.038</ArticleId><ArticleId IdType="pmc">PMC7713638</ArticleId><ArticleId IdType="pubmed">33279555</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchy P., Badur S. Who and When to Vaccinate against Influenza. Int. J. Infect. Dis. 2020;93:375–387. doi: 10.1016/j.ijid.2020.02.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.02.040</ArticleId><ArticleId IdType="pubmed">32109627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekiya T., Ohno M., Nomura N., Handabile C., Shingai M., Jackson D.C., Brown L.E., Kida H. Selecting and Using the Appropriate Influenza Vaccine for Each Individual. Viruses. 2021;13:971. doi: 10.3390/v13060971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13060971</ArticleId><ArticleId IdType="pmc">PMC8225103</ArticleId><ArticleId IdType="pubmed">34073843</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean H.Q., Belongia E.A. Influenza Vaccine Effectiveness: New Insights and Challenges. Cold Spring Harb. Perspect. Med. 2021;11:a038315. doi: 10.1101/cshperspect.a038315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a038315</ArticleId><ArticleId IdType="pmc">PMC8168527</ArticleId><ArticleId IdType="pubmed">31988202</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross P.A. The Efficacy of Influenza Vaccine in Elderly Persons. Ann. Intern. Med. 1995;123:518. doi: 10.7326/0003-4819-123-7-199510010-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-123-7-199510010-00008</ArticleId><ArticleId IdType="pubmed">7661497</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Loeches I., van Someren Gréve F., Schultz M.J. Bacterial Pneumonia as an Influenza Complication. Curr. Opin. Infect. Dis. 2017;30:201–207. doi: 10.1097/QCO.0000000000000347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000347</ArticleId><ArticleId IdType="pubmed">27984245</ArticleId></ArticleIdList></Reference><Reference><Citation>Cates C.J., Rowe B.H. Vaccines for Preventing Influenza in People with Asthma. Cochrane Database Syst. Rev. 2013;2013:CD000364. doi: 10.1002/14651858.CD000364.pub4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000364.pub4</ArticleId><ArticleId IdType="pubmed">11034684</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasileiou E., Sheikh A., Butler C., El Ferkh K., von Wissmann B., McMenamin J., Ritchie L., Schwarze J., Papadopoulos N.G., Johnston S.L., et al. Effectiveness of Influenza Vaccines in Asthma: A Systematic Review and Meta-Analysis. Clin. Infect. Dis. 2017;65:1388–1395. doi: 10.1093/cid/cix524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix524</ArticleId><ArticleId IdType="pmc">PMC5850022</ArticleId><ArticleId IdType="pubmed">28591866</ArticleId></ArticleIdList></Reference><Reference><Citation>Clohisey S., Baillie J.K. Host Susceptibility to Severe Influenza A Virus Infection. Crit. Care. 2019;23:303. doi: 10.1186/s13054-019-2566-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2566-7</ArticleId><ArticleId IdType="pmc">PMC6729070</ArticleId><ArticleId IdType="pubmed">31488196</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z., Liu L.F., Jiang Y.N., Tang L.P., Li W., Ouyang S.H., Tu L.F., Wu Y.P., Gong H.B., Yan C.Y., et al. Novel Insights into Stress-Induced Susceptibility to Influenza: Corticosterone Impacts Interferon-β Responses by Mfn2-Mediated Ubiquitin Degradation of MAVS. Signal Transduct. Target. Ther. 2020;5:202. doi: 10.1038/s41392-020-00238-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00238-z</ArticleId><ArticleId IdType="pmc">PMC7499204</ArticleId><ArticleId IdType="pubmed">32943610</ArticleId></ArticleIdList></Reference><Reference><Citation>Mettelman R.C., Thomas P.G. Human Susceptibility to Influenza Infection and Severe Disease. Cold Spring Harb. Perspect. Med. 2021;11:a038711. doi: 10.1101/cshperspect.a038711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a038711</ArticleId><ArticleId IdType="pmc">PMC8091954</ArticleId><ArticleId IdType="pubmed">31964647</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause J.C., Tumpey T.M., Huffman C.J., McGraw P.A., Pearce M.B., Tsibane T., Hai R., Basler C.F., Crowe J.E. Naturally Occurring Human Monoclonal Antibodies Neutralize Both 1918 and 2009 Pandemic Influenza A (H1N1) Viruses. J. Virol. 2010;84:3127–3130. doi: 10.1128/JVI.02184-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02184-09</ArticleId><ArticleId IdType="pmc">PMC2826039</ArticleId><ArticleId IdType="pubmed">20042511</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie G., Liu G.J., Deslauriers J., Fan Z.M. Pneumonectomy for Chronic Inflammatory Lung Disease: Indications and Complications. Chin. Med. J. 2010;123:1216–1219. doi: 10.3760/cma.j.issn.0366-6999.2010.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0366-6999.2010.09.021</ArticleId><ArticleId IdType="pubmed">20529566</ArticleId></ArticleIdList></Reference><Reference><Citation>Blyth D.F. Pneumonectomy for Inflammatory Lung Disease✩. Eur. J. Cardio-Thorac. Surg. 2000;18:429–434. doi: 10.1016/S1010-7940(00)00526-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(00)00526-1</ArticleId><ArticleId IdType="pubmed">11024380</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>